🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier Universitaire de Besancon
NCT07663669 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who developed antibody-mediated rejection and were treated with extracorporeal photopheresis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Kidney transplant recipients followed at the University Hospitals of Besançon and Lille between September 1, 2016, and August 31, 2023 * Patients with antibody-mediated rejection (as confirmed by histological analysis of the renal biopsy) * Rejection treated with extracorporeal photopheresis * Subjects who do not object to the use of their personal data and/or biological samples * Subjects affiliated with, or beneficiaries of, the French social security system Exclusion Criteria: * Patients with acute rejection * Pregnant women, women in labor, or breastfeeding mothers * Individuals deprived of liberty by judicial or administrative decision; individuals receiving compulsory psychiatric care; or individuals admitted to a healthcare or social institution for reasons other than research participation * Minors * Adults under legal protection or unable to provide informed consent * Subjects without health insurance coverage * Subjects currently within an exclusion period from another study, or as listed in the "national volunteer registry"
💊

What it tests

  • Not listed
📍

Where

1 site
Centre Hospitalier Universitaire de Besançon
Besançon, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy